Copegus and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copegus (ribavirin) and Fenofibrate (fenofibrate). Common drug interactions include hyperlipasaemia among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Copegus and Fenofibrate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Copegus?

Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

On Jul, 26, 2026

11 people who take Copegus and Fenofibrate together, and have interactions are studied.

Copegus and Fenofibrate drug interactions.

What are the common drug interactions of Copegus and Fenofibrate, by gender? *:

female:

Hyperlipasaemia (an abnormally high concentration of fats or lipids in the blood)
Hyperamylasaemia (acute pancreatitis in which serum amylase is usually elevated more than 4-fold)

male:

Anaemia (lack of blood)
Chills (felling of cold)
Exfoliative rash (scaly red generalized skin rash)
Pruritus generalised (generalized itching)
Psoriasis (immune-mediated disease that affects the skin)
Thirst
Weight decreased
Feeling jittery
Haemoglobin decreased
Irritability

What are the common drug interactions of Copegus and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dermatosis (a disease of the skin, esp. one that does not cause inflammation)
Erythrodermic psoriasis (generalized redness of the skin)
Exfoliative rash (scaly red generalized skin rash)
Pruritus generalised (generalized itching)
Psoriasis (immune-mediated disease that affects the skin)
Thirst
Weight decreased
Anaemia (lack of blood)
Chills (felling of cold)
Pneumonia

50-59:

Hyperlipasaemia (an abnormally high concentration of fats or lipids in the blood)
Hyperamylasaemia (acute pancreatitis in which serum amylase is usually elevated more than 4-fold)
Asthenia (weakness)

60+:

n/a

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 36.36%
Lipids Increased (excess lipid in body): 3 people, 27.27%
Stress And Anxiety: 3 people, 27.27%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 18.18%
Sleep Disorder: 2 people, 18.18%
Hiv Infection: 1 person, 9.09%
Bipolar Disorder (mood disorder): 1 person, 9.09%
Depression: 1 person, 9.09%
Dyslipidaemia (abnormal amount of lipids): 1 person, 9.09%
Hepatitis C Virus Test Positive: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Copegus and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously